Our findings suggest that the two incretin-based therapies are not associated with an increased or decreased risk of depression or self-harm.
No takes yet. Share an insight, caveat, or question.
Gamble et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: